Article Text

Download PDFPDF
Original article
Interlamellar cohesion after corneal crosslinking using riboflavin and ultraviolet A light
  1. G Wollensak1,
  2. E Spörl2,
  3. C Mazzotta3,
  4. T Kalinski4,
  5. S Sel5
  1. 1Eye Laser Institute, Halle, Germany
  2. 2Department of Ophthalmology, Technical University of Dresden, Dresden, Germany
  3. 3Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy
  4. 4Department of Pathology, University of Magdeburg, Magdeburg, Germany
  5. 5Department of Ophthalmology, Martin-Luther-University, Halle, Germany
  1. Correspondence to Dr Gregor Wollensak, Wildentensteig 4, D-14195 Berlin, Germany; gwollens{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


Corneal crosslinking treatment of progressive keratoconus using the photosensitiser riboflavin and ultraviolet A light (UVA) was introduced by Wollensak et al1 in Germany in 2003 and has become increasingly popular in recent years.2 3 Long-term results have confirmed the earlier positive results.3

The success of the new crosslinking method in the treatment of progressive keratoconus is based primarily on its biomechanical stiffening effect, stabilising the corneal collagen fibril …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles

  • At a glance
    Harminder S Dua Arun D Singh